
Acaduceus Pharmaceutics Inc Profile last edited on: 3/4/14
CAGE: 552P4
UEI:
Business Identifier: proprietary molecules in the field of targeted molecular therapeutics, molecular imaging, nanobiotechnology, and stem cells Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
11171 Bubb Road
Cupertino, CA 95014
Cupertino, CA 95014
(408) 306-5635 |
jennywu@acaduceuspharma.com |
www.acaduceuspharma.com |
Location: Single
Congr. District: 18
County: Santa Clara
Congr. District: 18
County: Santa Clara
Public Profile
Acaduceus Pharmaceutics Inc. expedites the development and commercialization of innovative proprietary molecules in the field of targeted molecular therapeutics, molecular imaging, nanobiotechnology, and stem cells with initial applications in the areas of oncologic and cardiovascular molecular medicine. Acaduceus Pharmaceutics Inc. has several molecular imaging and therapy leads in various stages of development.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2011 | 1 | NIH | $236,000 | |
Project Title: Phage Display Peptide Probes For Imaging Early Response To Cancer Therapy | ||||
2009 | 1 | NIH | $159,988 | |
Project Title: Targeted Prodrug Chemotherapy For Prostate Cancer | ||||
2009 | 1 | NIH | $100,000 | |
Project Title: Dual Integrin And Grpr Targeted Radiotherapy Of Prostate Cancer |
Key People / Management
Jenny C Wu -- President
Company News
There are no news available.